12664775

Source:http://linkedlifedata.com/resource/pubmed/id/12664775

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017168, umls-concept:C1522326, umls-concept:C1547011, umls-concept:C1879746
pubmed:issue	1
pubmed:dateCreated	2003-3-31
pubmed:abstractText	Current pharmacology being applied to gastroenterology develops in the following direction of production of antisecretory preparations: from histamine H2-receptor blockers and proton pump inhibitors to monoisomers of the latter, which makes it possible to optimize the drug therapy of gastroesophageal reflux disease.
pubmed:language	rus
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101144944
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	1682-8658
pubmed:author	pubmed-author:BalashovaN NNN, pubmed-author:MaevI VIV
pubmed:issnType	Print
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5-11, 181
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12664775-Gastroesophageal Reflux, pubmed-meshheading:12664775-Humans, pubmed-meshheading:12664775-Practice Guidelines as Topic
pubmed:year	2003
pubmed:articleTitle	[Modern aspects of treating gastroesophageal reflux disease].
pubmed:affiliation	Moscow Medical Institute of Stomatology.
pubmed:publicationType	Journal Article, English Abstract, Review